CAS 11021-35-5

D-erythro-α-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-4-ethyl-1-methyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)

CAS: 11021-35-5

Formel: C₁₇H₃₃ClN₂O₆S

Reinheit: 95%

Farbe und Form: Solid

Molekulargewicht: 428.9717

Ref: IN-DA008W92

D-erythro-α-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-4-ethyl-1-methyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)

CAS: 11021-35-5

D-erythro-α-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-4-ethyl-1-methyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)

Reinheit: ≥95%

Molekulargewicht: 428.97g/mol

Ref: 54-OR1075447

Lincomycin B HCl

CAS: 11021-35-5

Formel: C₁₇H₃₂N₂O₆S·HCl

Farbe und Form: Pale Yellow Solid

Molekulargewicht: 392.51 36.46

Ref: 4Z-L-093022

Lincomycin B hydrochloride

CAS: 11021-35-5

Ref: 7W-GC6924

Lincomycin B Hydrochloride

Kontrolliertes Produkt

CAS: 11021-35-5

Stability Hygroscopic
Applications Lincomycin (L466200) analog.
References Argoudelis, A.D., et al.: Biochemistry, 4, 698 (1965), Magerlein, B.J. , et al.: Antimicrob. Agents Chemother., 1966, 727 (1966),

Formel: C₁₇H₃₃ClN₂O₆S

Farbe und Form: Neat

Molekulargewicht: 428.97

Ref: TR-L466225

Lincomycin B hydrochloride

CAS: 11021-35-5

Inhibitor of protein synthesis; lincosamide

Formel: C₁₇H₃₃ClN₂O₆S

Reinheit: Min. 95%

Molekulargewicht: 428.97 g/mol

Ref: 3D-AL16774